Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2839531 | Clínica e Investigación en Arteriosclerosis | 2015 | 4 Pages |
Abstract
In the Catalonian Institute of health there are 2 well-established circumstances for indicating lipid-lowering drug treatment with statins in the primary prevention of ischaemic heart disease. These are, severe hypercholesterolaemia, with a low density lipoprotein cholesterol equal to or greater than 240Â mg/dL, or above 130Â mg/dL when the coronary risk is equal to or greater than 10% at 10 years. There are data that suggest that these 2 criteria are not the only ones used in routine clinical practice, as such that the majority of patients to whom it is indicated, do not meet either of these 2 conditions. This study aims to determine the characteristics of the patients when statins are indicated outside the aforementioned circumstances. It is concluded that around 40% of patients have clinical characteristics that could justify the treatment. The level of suitability could not be established in about 33% of the patients, due to not being able to determine the coronary risk.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
Cinta Estrada Alifonso, Jordi Vilaseca Canals, M. Ángeles Méndez TrÃas, Silvia Lozano Ovalle, Javier Jusmet Miquel, Victoria Torres Machado, Esteban Castro Rivera,